Tag Archives: trial

Pfizer Whistleblower Sinks Vaccine Trial Integrity

Yet again, mainstream media have completely ignored what should have been front-page news. According to a whistleblower who worked on Pfizer’s Phase 3 COVID jab trial in the fall of 2020, data were falsified, patients were unblinded, the company hired poorly trained people to administer the injections, and follow-up on reported side effects lagged way… Read More »

NIH ‘very concerned’ about serious side effect in AstraZeneca coronavirus vaccine trial

“The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader of viral research at the National Institute for Neurological Disorders and Stroke, an NIH division. “Everyone’s hopes are on a vaccine, and if you have a major complication the whole thing could get derailed.” A great deal… Read More »

Merck scraps Keytruda lung cancer trial adding Bristol Myers’ Yervoy. What about the Opdivo combo?

Merck’s Keytruda is without doubt the king in previously untreated non-small cell lung cancer, but the company wanted to see whether adding another immuno-oncology agent from rival Bristol Myers Squibb would offer additional benefit. Turns out, doing that adds more harm and no good. Merck decided to stop adding Bristol Myers’ CTLA-4 inhibitor Yervoy to Keytruda in… Read More »

Novartis eyes 3rd Kymriah indication with follicular lymphoma trial win

Novartis is hoping a third indication will help position Kymriah better against Gilead Sciences’ rival Yescarta in the CAR-T race—and it has positive early clinical results to back its case. Kymriah has hit its goal of eradicating signs of cancer in patients with relapsed or refractory follicular lymphoma (r/r FL) at an interim analysis of the phase 2 Elara… Read More »